John G. Cooper's most recent trade in Rockwell Medical Inc was a trade of 36,111 Common Stock done . Disclosure was reported to the exchange on May 21, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Rockwell Medical Inc | John G. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 36,111 | 95,451 (0%) | 0% | 0 | Common Stock | |
Rockwell Medical Inc | John G. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 24,715 | 155,594 (0%) | 0% | 0 | Common Stock | |
Rockwell Medical Inc | John G. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 25,000 | 130,879 (0%) | 0% | 0 | Common Stock | |
Rockwell Medical Inc | John G. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 72,857 | 72,857 | - | - | Stock Option (Right to Buy) | |
Rockwell Medical Inc | John G. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 50,000 | 105,879 (0%) | 0% | 0 | Common Stock | |
Rockwell Medical Inc | John G. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2020 | 36,000 | 55,879 (0%) | 0% | 0 | Common Stock | |
Rockwell Medical Inc | John G. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2020 | 34,024 | 34,024 | - | - | Stock Option (Right to Buy) |